| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Dec 23, 2022 | Dec 23, 2022 | Vivo Opportunity, LLC 10% | Buy | $7.25 | $5M | +10.23% |
| Dec 23, 2022 | Dec 23, 2022 | Lu Hongbo Dir | Buy | $7.25 | $5M | +14.88% |
| Nov 23, 2022 | Nov 28, 2022 | Lav Biosciences Fund V, L.P. 10% | Sell | $5.5 | $8M | -45.23% |
| Sep 07, 2022 | Sep 09, 2022 | Vivo Opportunity, LLC 10% | Buy | $3.6 | $2M | +9.23% |
| Sep 07, 2022 | Sep 09, 2022 | Lu Hongbo Dir | Buy | $3.6 | $2M | +14.35% |
| Aug 16, 2022 | Aug 18, 2022 | Orbimed Advisors LLC Dir 10% | Buy | $2.42 | $9M | +82.88% |
| Aug 16, 2022 | Aug 18, 2022 | Gordon Carl L Dir 10% | Buy | $2.42 | $9M | +82.88% |
| Aug 12, 2022 | Aug 17, 2022 | Vivo Opportunity, LLC 10% | Buy | $2.66 | $7M | +27.91% |
| Aug 12, 2022 | Aug 17, 2022 | Lu Hongbo Dir | Buy | $2.66 | $7M | +46.81% |
| May 31, 2022 | Jun 09, 2022 | Yoon Seokho Bryan COO GC | Buy | $1.47 | $11,254 | +50.00% |
| May 31, 2022 | Jun 09, 2022 | Vignola Mark J. CFO | Buy | $1.47 | $11,254 | +50.00% |
| May 31, 2022 | Jun 09, 2022 | Sundaram Senthil Vel CEO | Buy | $1.47 | $11,254 | +50.00% |
| Feb 09, 2021 | Feb 09, 2021 | Gordon Carl L Dir 10% | Buy | $17 | $8M | +17.27% |
| Feb 09, 2021 | Feb 09, 2021 | Orbimed Advisors LLC Dir 10% | Buy | $17 | $8M | +17.27% |
| Feb 09, 2021 | Feb 09, 2021 | Vivo Capital Viii, LLC 10% | Buy | $17 | $8M | +15.08% |
| Feb 09, 2021 | Feb 09, 2021 | Flynn James E Possible Member of 10% Group 10% | Buy | $17 | $11M | +21.82% |